408 related articles for article (PubMed ID: 25474204)
41. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
[TBL] [Abstract][Full Text] [Related]
42. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses.
Busquets-Garcia A; Puighermanal E; Pastor A; de la Torre R; Maldonado R; Ozaita A
Biol Psychiatry; 2011 Sep; 70(5):479-86. PubMed ID: 21684528
[TBL] [Abstract][Full Text] [Related]
43. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
Alhouayek M; Lambert DM; Delzenne NM; Cani PD; Muccioli GG
FASEB J; 2011 Aug; 25(8):2711-21. PubMed ID: 21551239
[TBL] [Abstract][Full Text] [Related]
44. The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats.
Jiang SK; Zhang M; Tian ZL; Wang M; Zhao R; Wang LL; Li SS; Liu M; Li JY; Zhang MZ; Guan DW
Eur J Pharmacol; 2015 Aug; 761():1-10. PubMed ID: 25912803
[TBL] [Abstract][Full Text] [Related]
45. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
[TBL] [Abstract][Full Text] [Related]
46. JZL184, as a monoacylglycerol lipase inhibitor, down-regulates inflammation in a cannabinoid pathway dependent manner.
Rahmani MR; Shamsizadeh A; Moghadam-Ahmadi A; Bazmandegan G; Allahtavakoli M
Biomed Pharmacother; 2018 Jul; 103():1720-1726. PubMed ID: 29864962
[TBL] [Abstract][Full Text] [Related]
47. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.
Kleschevnikov AM; Belichenko PV; Faizi M; Jacobs LF; Htun K; Shamloo M; Mobley WC
J Neurosci; 2012 Jul; 32(27):9217-27. PubMed ID: 22764230
[TBL] [Abstract][Full Text] [Related]
48. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.
Fucich EA; Stielper ZF; Cancienne HL; Edwards S; Gilpin NW; Molina PE; Middleton JW
J Neurophysiol; 2020 Feb; 123(2):707-717. PubMed ID: 31913777
[TBL] [Abstract][Full Text] [Related]
49. Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke.
Choi SH; Arai AL; Mou Y; Kang B; Yen CC; Hallenbeck J; Silva AC
Stroke; 2018 Mar; 49(3):718-726. PubMed ID: 29440474
[TBL] [Abstract][Full Text] [Related]
50. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.
Marino S; de Ridder D; Bishop RT; Renema N; Ponzetti M; Sophocleous A; Capulli M; Aljeffery A; Carrasco G; Gens MD; Khogeer A; Ralston SH; Gertsch J; Lamoureux F; Heymann D; Rucci N; Idris AI
EBioMedicine; 2019 Jun; 44():452-466. PubMed ID: 31151929
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats.
Sticht MA; Long JZ; Rock EM; Limebeer CL; Mechoulam R; Cravatt BF; Parker LA
Br J Pharmacol; 2012 Apr; 165(8):2425-35. PubMed ID: 21470205
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
Muldoon PP; Chen J; Harenza JL; Abdullah RA; Sim-Selley LJ; Cravatt BF; Miles MF; Chen X; Lichtman AH; Damaj MI
Br J Pharmacol; 2015 Feb; 172(3):869-82. PubMed ID: 25258021
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.
Terrone G; Pauletti A; Salamone A; Rizzi M; Villa BR; Porcu L; Sheehan MJ; Guilmette E; Butler CR; Piro JR; Samad TA; Vezzani A
Epilepsia; 2018 Jan; 59(1):79-91. PubMed ID: 29171003
[TBL] [Abstract][Full Text] [Related]
54. Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.
Paredes-Ruiz KJ; Chavira-Ramos K; Galvan-Arzate S; Rangel-López E; Karasu Ç; Túnez I; Skalny AV; Ke T; Aschner M; Orozco-Morales M; Colín-González AL; Santamaría A
Neurotox Res; 2023 Dec; 41(6):514-525. PubMed ID: 37458923
[TBL] [Abstract][Full Text] [Related]
55. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).
Aaltonen N; Kedzierska E; Orzelska-Górka J; Lehtonen M; Navia-Paldanius D; Jakupovic H; Savinainen JR; Nevalainen T; Laitinen JT; Parkkari T; Gynther M
J Pharmacol Exp Ther; 2016 Oct; 359(1):62-72. PubMed ID: 27451409
[TBL] [Abstract][Full Text] [Related]
56. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
[TBL] [Abstract][Full Text] [Related]
57. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
[TBL] [Abstract][Full Text] [Related]
58. Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease.
Chen R; Zhang J; Wu Y; Wang D; Feng G; Tang YP; Teng Z; Chen C
Cell Rep; 2012 Nov; 2(5):1329-39. PubMed ID: 23122958
[TBL] [Abstract][Full Text] [Related]
59. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
[TBL] [Abstract][Full Text] [Related]
60. JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice.
Marino S; Carrasco G; Li B; Shah KM; Lath DL; Sophocleous A; Lawson MA; Idris AI
Calcif Tissue Int; 2020 Jul; 107(1):72-85. PubMed ID: 32285169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
